首页 | 本学科首页   官方微博 | 高级检索  
     

银屑病发病机理及药物治疗进展
引用本文:周密妹,姚伟星. 银屑病发病机理及药物治疗进展[J]. 抗感染药学, 2006, 3(3): 97-101
作者姓名:周密妹  姚伟星
作者单位:武汉科技大学附属医院临床药学室,湖北,武汉,430064;华中科技大学同济医学院药理系,湖北,武汉,430030
摘    要:回顾近年来对银屑病病因和发病机理研究的以及用软化剂、角质促进剂、地蒽酚、焦油、外用皮质激素、维生素D3同类药、维A酸类、甲氨蝶呤、环孢素、他克莫司和PUVA疗法抗银屑病治疗的进展。

关 键 词:银屑病  发病机理  药物治疗
文章编号:1672-7878(2006)03-0097-05
收稿时间:2006-01-25
修稿时间:2006-01-252006-02-28

Inducing Mechanism and Recent Cases of Drug Treatment for Psoriasis
ZHOU Mi-mei,YAO Wei-xing. Inducing Mechanism and Recent Cases of Drug Treatment for Psoriasis[J]. Anti-infection Pharmacy, 2006, 3(3): 97-101
Authors:ZHOU Mi-mei  YAO Wei-xing
Affiliation:1. Institute of Clinical Pharmacy, The Affiliated Hospital of Wuhan University of Science and Technology, Wuhan Hubei 430064,china;2.Institute of Pharmacology,Tongji Medical College of Huazhong University of Science and Technology,Wuhan Hubei 430030,China
Abstract:The pathogenesis and treatment of psoriasis are reviewed. Topical treatments consist of emollients and keratolytic agents, anthralin, coal tar, corticosteroids, vitamin D3 analogues, topical retinoids, and topical psoralens plus ultraviolet A light. In patients who do not respond adequately to topical therapy, oral or injectable therapy, such as oral retiniods, methotrexate, cyclosporine, tacrolimus, and oral psoralens plus UVA light, may be warranted.
Keywords:Psoriasis  pathogenesis  drug treatments  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号